Roles of Raf-1 kinase in pancreatic beta-cells
A decrease in functional β-cell mass is key in the pathogenesis of both type 1 and type 2 diabetes and in the failure of transplanted islet grafts. Knowledge of the endogenous regulators of β-cell proliferation and survival are important for understanding the physiological regulation of β-cell mass....
Main Author: | |
---|---|
Language: | English |
Published: |
University of British Columbia
2010
|
Online Access: | http://hdl.handle.net/2429/27641 |
id |
ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-27641 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-LACETR-oai-collectionscanada.gc.ca-BVAU.2429-276412014-03-26T03:37:07Z Roles of Raf-1 kinase in pancreatic beta-cells Alejandro, Emilyn Uy A decrease in functional β-cell mass is key in the pathogenesis of both type 1 and type 2 diabetes and in the failure of transplanted islet grafts. Knowledge of the endogenous regulators of β-cell proliferation and survival are important for understanding the physiological regulation of β-cell mass. We have shown that physiological concentrations of the insulin hormone act directly on β-cells to promote proliferation and survival, but its mechanisms remain unclear. We hypothesized that Raf-1, a kinase upstream of both ERK1/2 and Bad, is a critical target of insulin in β-cells. To test this hypothesis, we treated primary β-cells and MIN6 β-cells with multiple insulin concentrations and examined putative downstream targets. Low concentrations of insulin rapidly activated Raf-1 and ERK1/2 in primary islets and MIN6 cells. The phosphorylation of ERK1/2 by insulin was eliminated by exposure to a Raf inhibitor or transfection with a dominant-negative Raf-1 mutant. Insulin enhanced the interaction between mitochondrial Raf-1 and Bad, promoting the inactivation of pro-apoptotic Bad. Over-expression of Raf-1 was sufficient to increase proliferation in the absence of insulin, whereas a dominant-negative Raf-1 reduced proliferation in the presence of insulin. We also tested if Raf-1 signalling plays an important role in β-cell survival both in vitro and in vivo. We utilized a Raf inhibitor and dominant-negative Raf-1 mutants to block basal Raf-1 signalling in serum free conditions in vitro and the Cre-lox recombination system to obtain a β-cell specific deletion of the Raf-1 gene in vivo. Our data show that blocking basal Raf-1 signalling in vitro caused apoptosis. Preliminary data indicate that β-cell specific Raf-1 knockout mice are viable, have increased fasting basal blood glucose levels and have impaired glucose tolerance compared to littermate controls, consistent with the concept that Raf-1 plays an important role in β-cell survival. Together, these findings have significant implications for the understanding of insulin signalling pathway in β-cells and the regulation of β-cell mass. 2010-08-23T17:39:01Z 2010-08-23T17:39:01Z 2010 2010-08-23T17:39:01Z 2010-11 Electronic Thesis or Dissertation http://hdl.handle.net/2429/27641 eng http://creativecommons.org/licenses/by-nc-nd/3.0/ Attribution-NonCommercial 2.5 Canada University of British Columbia |
collection |
NDLTD |
language |
English |
sources |
NDLTD |
description |
A decrease in functional β-cell mass is key in the pathogenesis of both type 1 and type 2 diabetes and in the failure of transplanted islet grafts. Knowledge of the endogenous regulators of β-cell proliferation and survival are important for understanding the physiological regulation of β-cell mass. We have shown that physiological concentrations of the insulin hormone act directly on β-cells to promote proliferation and survival, but its mechanisms remain unclear. We hypothesized that Raf-1, a kinase upstream of both ERK1/2 and Bad, is a critical target of insulin in β-cells. To test this hypothesis, we treated primary β-cells and MIN6 β-cells with multiple insulin concentrations and examined putative downstream targets. Low concentrations of insulin rapidly activated Raf-1 and ERK1/2 in primary islets and MIN6 cells. The phosphorylation of ERK1/2 by insulin was eliminated by exposure to a Raf inhibitor or transfection with a dominant-negative Raf-1 mutant. Insulin enhanced the interaction between mitochondrial Raf-1 and Bad, promoting the inactivation of pro-apoptotic Bad. Over-expression of Raf-1 was sufficient to increase proliferation in the absence of insulin, whereas a dominant-negative Raf-1 reduced proliferation in the presence of insulin. We also tested if Raf-1 signalling plays an important role in β-cell survival both in vitro and in vivo. We utilized a Raf inhibitor and dominant-negative Raf-1 mutants to block basal Raf-1 signalling in serum free conditions in vitro and the Cre-lox recombination system to obtain a β-cell specific deletion of the Raf-1 gene in vivo. Our data show that blocking basal Raf-1 signalling in vitro caused apoptosis. Preliminary data indicate that β-cell specific Raf-1 knockout mice are viable, have increased fasting basal blood glucose levels and have impaired glucose tolerance compared to littermate controls, consistent with the concept that Raf-1 plays an important role in β-cell survival. Together, these findings have significant implications for the understanding of insulin signalling pathway in β-cells and the regulation of β-cell mass. |
author |
Alejandro, Emilyn Uy |
spellingShingle |
Alejandro, Emilyn Uy Roles of Raf-1 kinase in pancreatic beta-cells |
author_facet |
Alejandro, Emilyn Uy |
author_sort |
Alejandro, Emilyn Uy |
title |
Roles of Raf-1 kinase in pancreatic beta-cells |
title_short |
Roles of Raf-1 kinase in pancreatic beta-cells |
title_full |
Roles of Raf-1 kinase in pancreatic beta-cells |
title_fullStr |
Roles of Raf-1 kinase in pancreatic beta-cells |
title_full_unstemmed |
Roles of Raf-1 kinase in pancreatic beta-cells |
title_sort |
roles of raf-1 kinase in pancreatic beta-cells |
publisher |
University of British Columbia |
publishDate |
2010 |
url |
http://hdl.handle.net/2429/27641 |
work_keys_str_mv |
AT alejandroemilynuy rolesofraf1kinaseinpancreaticbetacells |
_version_ |
1716655678216470528 |